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 6  Abstract      
7 Surgical site infections are common in veterinary practice; their prevention is based on the 8 
preoperative use of topical antimicrobials at the surgical site to reduce resident bacteria to sub9 
pathogenic levels. Chlorhexidine gluconate (CHG) and Povidone-iodine (PI) are the most 10 popular 
options for preoperative skin preparation in veterinary practice due to their broad11 spectrum 
antibacterial properties. However increasing bacterial resistance to CHG and PI have  
12 been reported, therefore investigation into alternative antimicrobials such as Camellia sinensis  
13 (green tea: GT) is required.  The Kirby-Bauer disk diffusion method was used to test the  
14 antibacterial activity of four dilutions of CHG, PI and GT on the normal flora of animal skin,  
 15  represented by S. aureus, S. intermedius, S. uberis and S. pyogenes.  Zones of inhibition (ZOI)  
16 were measured to assess antimicrobial action. Kruskal-Wallis analyses with Mann-Whitney 17 
post-hoc tests determined differences in efficacy between the dilutions of antimicrobials for 18 each 
bacterium tested.   
19 All antimicrobials inhibited bacterial growth, CHG was more efficacious than PI and GT  
20 (P<0.0001; mean CHG: 24.02mm±2.05mm; mean PI: 4.46mm±1.35mm; mean GT:  
21 2.90mm±2.60mm). Although GT produced smaller ZOIs than PI, no significant differences in 22 
efficacy existed (P>0.05). The results suggest that CHG is the best antimicrobial for  
23 preoperative skin preparation. GT did produce an antibacterial effect on three of the four 24 bacteria, 
although this was inferior to the existing veterinary products used. Therefore GT in  
 25  the formulation tested is not recommended for use as a veterinary antimicrobial, however,  
 2  
  
further investigations into the potential of the active ingredients in different formulations and 25 
concentrations are warranted.   26 
Key words: Antimicrobial resistance; Green tea; Surgical site infection; Veterinary nursing  27 
Highlights:   28 
1. Chlorohexidine has a superior topical antimicrobial activity in vitro than povidone-iodine.   29 
2. Green tea has limited antimicrobial activity but this is inferior to established veterinary 30 
topical antimicrobials.  31 
3. Chlorohexidine appears to be the most effective topical antimicrobial for surgical 32 
preparation of the veterinary patient.  33 
  34 
    35 
Introduction  36 
Surgical site infections (SSIs) are a type of iatrogenic infection occurring in wounds 37 
postoperatively which can be a potentially life-threatening surgical complication within human 38 
and veterinary medicine (Eugster et al., 2004; Cho et al., 2008; Hemani and Lepor, 2009). SSIs 39 
can result in pain, delayed healing and wound breakdown and, because preventable, could be 40 
deemed ‘unavoidable suffering’ (Jennings and Berdory, 2010). Therefore effective SSI 41 
prevention is essential to maintain the health and welfare of surgical patients.   42 
  43 
It is widely believed that the patient’s skin is the main source of surgical wound contamination, 44 
with Staphylococci and Streptococci bacterial species most frequently cultured from veterinary 45 
SSIs (Darouiche et al., 2010; Hutchinson, 2012; Roberts, 2013). These species represent the 46 
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normal bacteria of the skin and are usually non-pathogenic, but can cause infection when they 47 
enter a wound (Bowers, 2012; Roberts, 2013). SSIs account for 15% of human nosocomial 48 
infections, prolong hospitalisation and increase morbidity and mortality, in turn increasing the 49 
cost of surgery in humans (Durani and Leaper, 2008; Reichman and Greenberg, 2009). 50 
Veterinary SSI incidence occurs at an estimated 3% in surgical patients (Frey et al., 2006; 51 
Fitzpatrick and Solano, 2010; Turk et al., 2015) with livestock surgery that often occurs outside 52 
the surgical environment in situ increasing SSI risk >30% (Fubini and Ducharme, 2004; Weaver 53 
et al., 2005; Verwilghen and Singh, 2014). Investigations into the microbiology of SSIs have 54 
demonstrated wide bacterial diversity (Owens and Stoessel, 2008; Wolcott et al., 2009; Turk et 55 
al., 2015); causal bacteria implicated include Staphylococci species (74%), with Staphylococcus 56 
aureus and coagulase-negative Staphylococci most commonly reported (Owens and Stoessel,  57 
2008; Turk et al., 2015).    58 
An estimated 40-60% of SSIs are avoidable (Uckay et al., 2010) and prevention of SSIs can be 59 
relatively simple. Preoperative skin preparation1 (PSP) with an appropriate antimicrobial is 60 
commonly practiced by veterinary professionals to decrease resident bacteria to sub-pathogenic 61 
levels, reducing SSI risk (Durani and Leaper, 2008; Roberts, 2013). Prophylactic antibiotics 62 
were once recommended to prevent SSIs, however due to increasing bacterial antibiotic 63 
resistance these are no longer advised (Knights et al, 2012; Turk, 2013). The most commonly 64 
used antimicrobials in veterinary medicine are chlorhexidine gluconate (CHG) and 65 
Povodineiodine (PI) (Hemani and Lepor, 2009; Bowlt and Gasson, 2013; Rutter et al., 2014). 66 
Manufacturers recommend the use of undiluted product (BCM, 2013; Animalcare, 2014), 67 
however in veterinary practice antimicrobials are commonly diluted in a solution with water 68 
                                                 
1 Preoperative skin preparation: The reduction of resident and transient bacteria from the skin using swabs 
soaked with an antiseptic and applied to the skin in a methodological fashion, often followed by application of 
surgical spirit. It is impossible to make the skin sterile, so reduction of bacteria to sub-pathogenic levels is the 
aim (Bowers, 2012).  
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and soaked swabs used for application (McHugh et al, 2011; Aspinall, 2014). SSI risk increases 69 
if the dilution is too weak, providing inadequate antibacterial action (Kampf and Kramer, 2004;  70 
Evans et al., 2009). For example, it has been demonstrated that dilutions containing less than 71 
3% CHG reduce but do not eliminate bacteria, and are ineffective against Staphylococcus 72 
aureus (Evans et al., 2009; Montevecchi et al., 2013).    73 
  74 
CHG is an aqueous antimicrobial, effective against Gram-positive and negative bacteria, yeasts 75 
and some viruses (Hemani and Lepor, 2009; Reichman and Greenberg, 2009; Macias et al., 76 
2013). It has bactericidal action by disturbing bacterial cell membranes and increasing cell wall 77 
permeability, facilitating bacteriolysis (Popovich et al., 2009; Karki and Cheng, 2012; Edmiston 78 
et al., 2013). CHG binds to the surface of the skin to produce a residual effect, enabling lasting 79 
antibacterial activity long after application (Anderson et al., 2010; Sogawa et al., 2010). It is 80 
thought that CHG products are also able to delay the recolonization of resident bacteria (Rutter 81 
et al., 2014). PI is another popular topical antimicrobial choice, as it is broad-spectrum and safe 82 
for application to mucous membranes (Hemani and Lepor, 2009). It is a water-soluble complex 83 
of iodine and a carrier, polyvinylpyrrolidone, which acts as a reservoir of the active ingredient 84 
free iodine (Anderson et al., 2010). PI is an aqueous-based iodophor, whose antimicrobial 85 
properties relate to its ability to destroy bacterial proteins and DNA (Hemani and Lepor, 2009).  86 
PI is considered to have some level of persistence, although comparatively it is thought that 87 
CHG has a longer residual effect (Art, 2005; Sogawa et al., 2010; Pelligand, 2012). Few studies 88 
have compared the efficacy of PI with other antiseptics; however cultures from surgical sites 89 
30 minutes post-application have suggested that CHG is more effective than PI (Culligan et al., 90 
2005). Other studies have also reported a superior effect of CHG when compared to PI, with 91 
lowered colony counts at the surgical site after PSP (Art, 2007; Macias et al., 2013). 92 
Interestingly, limited research has evaluated the synergy between antimicrobials; synergism 93 
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between CHG and PI has been reported but further research into the potential combination of 94 
antimicrobials for SSI reduction in practice is needed (Anderson et al., 2010).   95 
  96 
Resistance to both CHG and PI has been recorded, therefore it is becoming increasingly 97 
important to establish novel, safe alternatives (Reichman and Greenberg, 2009; Anita et al., 98 
2015). There has been interest in the antimicrobial effects of tea for many years; recent in vitro 99 
and in vivo studies into Camellia sinensis (green tea: GT) have provided a better understanding 100 
of its antimicrobial properties (Kumar et al., 2012; Sharma et al., 2012). GT contains medically 101 
important compounds including polyphenols (Taylor et al., 2005; Silva et al., 2013) and 102 
flavonoids (Reygaert, 2014). Flavonoids, for example catechins, constitute approximately 103 
3040% of dry leaf weight and are thought to account for GT’s antimicrobial properties (Taylor 104 
et al., 2005; Almajano et al., 2008; Reygaert, 2014). Catechins have a direct antibacterial effect 105 
by binding to the lipid bilayer of bacterial cell membranes, thus causing damage and preventing 106 
bacteria forming biofilms (Reygaert, 2014). Fatty acids are a major component of the 107 
phospholipid bilayer of the cell membrane and there is evidence that GT catechins, especially 108 
epigallocatechin-3-gallate (ECGC), can also inhibit enzymes that are required for fatty acid 109 
synthesis (Singh et al., 2011; Wang and Ma, 2013) and DNA replication, enabling them to 110 
possess potent antibacterial activity (Grandišar et al., 2007).   111 
  112 
Mechanisms of action differ between antimicrobials; CHG affects cell membranes, PI targets 113 
intracellular molecules and GT uses a combination of both mechanisms (Li et al., 2006; Jones, 114 
2007; Durani and Leaper, 2008; Reygaert, 2014). Research to directly compare the efficacies 115 
of such antimicrobials has not yet been conducted, therefore this study aimed to provide a 116 
framework for further research into the potential use of Camellia sinensis (GT) in veterinary 117 
 6  
  
PSP, by comparing its efficacy at preventing bacterial growth of Staphylococci and Streptococci 118 
species to that of CHG and PI in vitro.    119 
  120 
Materials and Methods  121 
The Kirby-Bauer disk diffusion method (disk diffusion) was used to determine the in vitro 122 
susceptibility of Staphylococcus aureus (ATCC 25923), Staphylococcus intermedius (ATCC 123 
29663), Streptococcus uberis (ATCC 9927) and Streptococcus pyogenes (ATCC 19615) to 124 
dilutions of 4% CHG, 10% PI and GT (Block and Furman, 2002; Cappuccino and Sherman, 125 
2008; Hudzicki, 2013; Vetbact, 2015).   126 
  127 
Commercially available CHG (Hibiscrub™) and PI (Vetasept™) products contain 4% 128 
chorlohexidine gluconate and 10% PI, the active ingredient respectively. Based on previous 129 
research, 10%, 5%, 2.5% and 1.25% dilutions of CHG, PI and GT were prepared (Yassen et al., 130 
2011). A 0% dilution (distilled water) was used as a control. Fresh dilutions were prepared daily 131 
to avoid degradation. The appropriate measure of undiluted CHG or PI was mixed with sterile 132 
0.9% saline as a buffer to obtain 1ml of the required dilution; sufficient volume to impregnate 133 
six filter disks per plate. For example, the10% dilution was prepared using 0.9ml sterile saline 134 
mixed with 0.1ml CHG in a sterile Eppendorf tube.    135 
  136 
Dilutions of green tea were prepared using dried green tea leaves (Clipper®) and distilled water. 137 
For the 10% dilution, 10g loose dried green tea leaves was added to 90ml water; this was 138 
repeated for each dilution, for example 5g tea added to 95ml water for a 5% dilution. Following 139 
the manufacturer’s recommendations, distilled water was boiled, measured and left to cool for 140 
one minute before pouring over the leaves. The solution was stirred once and left to infuse for 141 
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two minutes. Then 1.5ml of the liquid was decanted into a sterile Eppendorf tube using an 142 
automatic pipette with a sterile tip, and allowed to cool before application to prevent heat 143 
destroying the bacteria. The process was repeated for each dilution of tea.  144 
  145 
Inoculation and Application of Antimicrobials  146 
Sixteen plates were prepared for inoculation with each bacterium: Staphylococcus aureus, 147 
Staphylococcus intermedius, Streptococcus uberis and Streptococcus pyogenes. The lawn 148 
method of inoculation was used to inoculate Mueller-Hinton agar plates to promote an even 149 
layer of bacterial growth, useful for susceptibility testing (Parija, 2009; Driscoll et al., 2012) 150 
(Fig. 1).  151 
Application of Filter Disks and Antimicrobials   152 
Following the Kirby-Bauer disk diffusion test protocol (Eucast, 2015), six filter disks were 153 
applied to the surface of the inoculated agar of each plate and pressed down gently with forceps 154 
to ensure complete contact with the agar. The disks were spaced evenly to allow visualisation 155 
of clear zones of inhibition (ZOI). Each filter disk represented a repeat therefore there were six 156 
repeats per antimicrobial dilution per bacterium (Parija, 2009).  An automatic pipette was then 157 
used to apply 10μl of antimicrobial to each filter disk, avoiding surface pooling which could 158 
cause inaccurate results. Plates were then incubated at 37˚C for 20 hours prior to collection of 159 
results (Hudzicki, 2013).  160 
  161 
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Data Collection  162 
The diameters of ZOIs (DZOIs) were measured in millimetres using Vernier callipers. In the 163 
case that two ZOIs overlapped, the radius of the zone was measured and multiplied by two to 164 
produce an estimate of the diameter. If there was no ZOI the bacterium was considered resistant, 165 
with DZOIs recorded as 0mm (Hudzicki, 2013).  166 
  167 
Data Analysis  168 
The mean and standard deviation for DZOI for the six filter disks (n=92) on each plate (n=16) 169 
for each bacterium were calculated using Microsoft Excel, version 2013. Data were analysed 170 
using Statistical Package for the Social Sciences, version 20. A series of Kruskal-Wallis 171 
analyses were undertaken to determine the presence of a difference between the DZOI, with 172 
increased diameters representing enhanced efficacy, for each of the four bacterial species, for 173 
dilutions within each antimicrobial, between the antibacterials and to compare synthetic versus 174 
natural products (Field, 2009). Subsequent post-hoc testing was completed using MannWhitney 175 
U tests with a bonferroni adjustment applied to the post-hoc alpha value due to the inclusion of 176 
repeated groups, to prevent the occurrence of Type I errors (revised significance level: P<0.016) 177 
(Field, 2009).   178 
  179 
Results  180 
All dilutions of CHG were effective at reducing bacterial growth in all species, demonstrated 181 
by clear zones of bacterial inhibition around the disks, and were larger than the other 182 
antimicrobials; dilutions of PI and GT were less effective at bacterial reduction, demonstrating 183 
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largely similar ZOI (Fig. 2). Significant differences were found between mean DZOIs for the 184 
three antimicrobials (P=0.0001). Subsequent post-hoc testing indicated CHG (mean ZOI:  185 
24.02mm±2.05) was more effective than both PI (mean ZOI: 4.46±1.35mm) and GT (mean  186 
ZOI: 2.90±2.60mm). No significant difference in DZOI was found between PI and GT 187 
(P=0.022).   188 
  189 
CHG versus PI  190 
CHG inhibited growth of all species of bacteria tested; in contrast, only 10% PI mimicked this 191 
action. Mean DZOIs for CHG across all dilutions (24.04±2.05mm) were larger than PI DZOIs 192 
(4.46±1.35mm), with the ZOI of 1.25% CHG 49% larger than 10% PI. Differences were 193 
exposed between the mean DZOI for the different dilutions of CHG and PI for all bacteria tested 194 
(P<0.0001) (Table 1). Enhanced efficacy was found for all dilutions of CHG compared to all 195 
dilutions of PI for all bacteria (P<0.001) (Fig. 2). Further significant differences in antimicrobial 196 
efficacy were exposed between the mean DZOIs of the variable dilutions of PI (P<0.0001); 197 
DZOI  diameter  expanded  with  increased  concentration 198 
 (10%:10.32±0.94mm;  199 
5%:4.44±3.65mm; 2.5%:1.37±2.38mm) (Table 1). In contrast, no significant difference in 200 
CHG efficacy was found between all dilutions, across all bacteria (P>0.05).  201 
  202 
Dilutions of Green Tea  203 
GT appeared effective against three of the four bacteria tested; 10%, 5% and 2.5% dilutions of 204 
GT were effective against S. pyogenes, in contrast only 10% GT was effective against S. aureus 205 
and S. uberis. S. intermedius was unaffected by the presence of GT, with no ZOI evident for 206 
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any dilution. The 10% dilution was most effective (mean DZOI: 7.17±4.23mm), whereas 2.5% 207 
produced the smallest effect (mean DZOI: 2.08±3.61mm) and 1.25% GT was ineffective 208 
against all bacteria (Table 2). No differences in efficacy (P>0.05) were found between the 209 
dilutions of GT when used on S. intermedius (Table 2). Efficacy did vary significantly (P<0.02) 210 
between dilutions against the remaining bacteria: the 10% dilution of GT exhibited an 211 
antimicrobial action against S. aureus and S. uberis, however all dilutions of GT prohibited 212 
growth of S. pyogenes (Table 3).   213 
  214 
Synthetic versus Natural Antimicrobials  215 
The synthetic antimicrobials produced a significantly higher mean DZOI (P<0.0001) for all 216 
bacteria species (mean DZOI: 14.24±1.59mm) when compared to GT (mean DZOI: 217 
2.90±2.60mm) (Fig. 3). Interestingly, no significant difference (P>0.05) was found between 218 
mean DZOIs of PI and GT, with the exception of S. intermedius (where GT was ineffective at 219 
all dilutions; P<0.001). However CHG was significantly more effective than GT against all 220 
bacteria tested (P<0.0001).  221 
Discussion  222 
CHG proved the superior antimicrobial against the bacterial species tested in this study; CHG 223 
has previously been reported to produce a superior effect in comparison to other antimicrobials 224 
including PI, supporting the observed results (Darouiche et al., 2010; Jarral et al., 2011; Kunkle 225 
et al., 2014). Manufacturers’ guidelines indicate that Vetasept and Hibiscrub are recommended 226 
for undiluted use during PSP (Animalcare, 2014, BCM, 2013), as there are no clear guidelines 227 
and conflicting recommendations for PSP with CHG within the veterinary literature it could be 228 
assumed that it could be used diluted or undiluted in veterinary practice (BCM, 2013; Aspinall, 229 
2014). The antimicrobial action of the dilutions tested here suggest this assumption would not 230 
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enhance the risk of SSIs. In contrast, the application of diluted PI reduced its antimicrobial 231 
action and could increase the risk of SSIs. In veterinary practice both PI and CHG are used 232 
diluted, perhaps at insufficient concentrations, and applied using soaked swabs (McHugh et al.,  233 
2012; Aspinall, 2014), often followed by application of iodophor alcohol (surgical spirit). 234 
Alcohol has been shown to have a short acting broad spectrum antimicrobial activity which 235 
complements the action of CHG (Hemani and Lepor, 2009). A dilution ratio of 50:50 CHG 236 
solution: water followed by a final surgical spirit application is therefore recommended for use 237 
for surgical site preparation in the veterinary patient (Roberts, 2013; Hemani and Lepor, 2009). 238 
. However further investigations into antimicrobial dilutions used in vivo and incidence of SSIs 239 
are warranted to determine the impact of common practices on   SSI risk.  240 
  241 
The comparison of relative dilutions of CHG and PI demonstrated that CHG produced a far 242 
superior effect when used on the bacteria tested, indicating that CHG should be the preferred 243 
choice for PSP in most surgeries. The superior antimicrobial action of CHG against the bacteria 244 
tested in this study, may be related to CHG’s 99% bacterial kill rate within 30 seconds of 245 
application coupled with its residual activity; this may have initially eliminated the bacteria in 246 
direct contact with the antimicrobial as it diffused through the agar, producing clear zones 247 
around the disks as less bacteria were available to colonize (Orpet and Welsh, 2010; Macias et 248 
al., 2013). Despite evidence of diffusion through the agar, PI and GT did not produce a 249 
comparative residual effect; however it is possible some regrowth occurred during incubation. 250 
It is possible that PI could produce a superior effect when used in vivo, therefore further research 251 
to determine this is indicated (Osuna et al., 1992).   252 
  253 
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It is commonly perceived that PI is effective at reducing resident skin bacteria so is often used 254 
in veterinary practice, whereas the results obtained here suggest poor efficacy (Bowers, 2012).  255 
These results may indicate an over-reliance on PI for SSI reduction in the veterinary industry 256 
(Hedalgo and Dominguez, 2001; Hemani and Lepor, 2009; Bowlt and Gasson, 2013). This is 257 
particularly true for large animal surgery where PI is often used, especially during field 258 
procedures, despite having been demonstrated to be less effective than CHG in these species 259 
(Desrochers et al., 1996, Wilson et al., 2011). The results suggest that CHG would be 260 
recommended as the superior produce for PSP, however as its use is contraindicated in certain 261 
surgeries such as ophthalmic, aural or neurosurgery, PI still plays an important role in SSI 262 
prevention in some cases (Denton, 2001; Roberts, 2013). These results could assist veterinary 263 
professionals make an informed decision on the best antimicrobial product for use during 264 
general PSP.   265 
  266 
pH can influence the antimicrobial activity of the products tested; PI is active at pH 3 to 5.5 267 
whereas Mueller-Hinton agar is pH 7.4±0.2, which could account for the reduced performance 268 
observed (Atlas and Snyder, 2006; Animalcare, 2014). It has been found that normal animal 269 
skin is approximately pH 6; although more acidic than Mueller-Hinton, this is still outside the 270 
active pH range of PI, which could adversely impact its efficacy in vivo (Meyer and Neurand, 271 
1991). No recommendations for pH are available for CHG. Contact times are another important 272 
factor in the determination of the efficacy of antimicrobials, with increasing time related to 273 
superior efficacy (Koburger et al., 2009). However Evans et al. (2009) found that the majority 274 
of veterinary nurses were unaware of contact times used during PSP, suggesting that educating 275 
veterinary professionals in the appropriate use of antimicrobials may be an equally important 276 
factor in future SSI reduction.  277 
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  278 
Efficacy of Green Tea  279 
Demand for natural products is growing in many industries, with particular interest in natural 280 
pharmaceuticals and an emphasis on antimicrobials due to increasing bacterial resistance 281 
(Jacob, 2014; Sharif et al., 2014; Ling et al., 2015). However, GT was not found to have 282 
comparative antimicrobial properties to CHG and PI. Ten percent GT was the most effective 283 
dilution tested (mean DZOI 7.16±4.23mm) and 2.5% the least effective (mean: 2.08±3.61mm). 284 
Growth within the GT ZOIs was evident, suggesting some concentrations were not sufficient to 285 
clear all bacteria. It is probable that the higher the concentration of GT, the more numerous the 286 
water-soluble catechins present. As these possess antibacterial properties, a direct correlation 287 
would be expected between increasing concentrations of GT and antibacterial activity (Cushnie 288 
and Lamb, 2005). A manufactured antimicrobial based on GT may be more appropriate for PSP 289 
than the infused preparation used here, to ensure adequate concentrations of catechins are 290 
present. Synergistic effects have also been observed when GT and antimicrobials are used 291 
concurrently. Therefore the addition of GT catechins to skin preparation products such as CHG 292 
and PI could enhance their antibacterial activity (Tiwari et al., 2005; Archana and Abraham, 293 
2011; Reygaert, 2014). Further research investigating GT used solely or in combination with 294 
other antimicrobials for SSI prevention is therefore needed.   295 
  296 
A sample of bacteria were selected here to represent normal which a diverse range of bacterial 297 
species (Grice and Segre, 2011). Therefore to fully determine the efficacy of an antimicrobial 298 
for skin preparation it should be tested on all bacteria that might be present in vivo. Future 299 
research could culture swabs taken directly from animal skin to test the efficacies of 300 
antimicrobials. It is also possible that in vitro results may not directly correlate with in vivo 301 
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efficacy (Hardy Diagnostics, 2015), consequently the conclusions drawn from this study should 302 
be interpreted with caution.   303 
  304 
Conclusions  305 
The results of this study advocate the use of CHG as the most effective topical antimicrobial for 306 
surgical preparation of the veterinary patient.  Whilst GT was shown to exhibit some 307 
antibacterial action against common skin bacteria, this was inferior to veterinary antimicrobials 308 
currently used in PSP. Therefore GT in the formulation tested is not recommended for use as a 309 
veterinary antimicrobial.   310 
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    530 
Tables  531 
Table 1: Significant differences observed between dilutions of Povidone-iodine.  532 
Zones of inhibition for each dilution of Povodine-iodine were tested to compare efficacy of the different dilutions 533 
across all bacterial species evaluated:  Staphylococcus aureus, Staphylococcus intermedius, Streptococcus uberis 534 
and Streptococcus pyogenes; ‘>’ indicates increased efficacy i.e. reduced diameters for zones of inhibition.   535 
  536 
Dilution of PI  Result  
10% > 5%  P=0.0001  
10% > 2.5%  P=0.0001  
10% > 1.25%  P=0.0001  
5% > 2.5%  P=0.0001  
5% > 1.25%  P=0.0001  
2.5% and 1.25%  P=0.039  
  537 
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Table 2: Mean diameters of zones of inhibition (mm) for each dilution of Green tea for each 539 
bacterium; ZOI: zone of inhibition.  540 
Mean zones of inhibition were measured for each bacteria species tested and an average overall zone of inhibition 541 
was calculated.    542 
Dilution rate  
Staphylococcus 
aureus  
Mean ZOI  
(mm)  
Staphylococcus 
intermedius  
Mean ZOI (mm)  
Streptococcus 
uberis  
Mean ZOI  
(mm)  
Streptococcus 
pyogenes  
Mean ZOI  
(mm)  
Mean ZOI 
across all 
bacterial 
species  
±standard 
deviation  
10%  9.67  0  8.25  10.75  7.16±4.23  
5%  0  0  0  9.33  2.33±4.04  
2.5%  0  0  0  8.33  2.08±3.61  
1.25%  0  0  0  0  0±0  
  543 
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Table 3: Differences observed between dilutions of Green tea; bold values represent 545 
significant results (Bonferroni adjusted P value<0.02; bold values indicate a significant 546 
difference exists).  547 
Zones of inhibition for each dilution of green tea were tested to compare efficacy of the different dilutions across 548 
the three bacterial species were growth was inhibited:  Staphylococcus aureus, Streptococcus uberis and 549 
Streptococcus pyogenes; ‘>’ indicates increased efficacy i.e. reduced diameters for zones of inhibition.   550 
Dilution rate  
Staphylococcus 
aureus  
Streptococcus 
uberis  
Streptococcus 
pyogenes  
10% > 5%  P=0.002  P=0.015  P=0.009  
10% > 2.5%  P=0.002  P=0.015  P=0.002  
10% > 1.25%  P=0.002  P=0.015  P=0.002  
5% > 2.5%  P=1.000  P=1.000  P=0.015  
5% > 1.25%  P=1.000  P=1.000  P=0.002  
2.5% > 1.25%  P=1.000  P=1.000  P=0.002  
     551 
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Figure legends  552 
  553 
Fig. 1: Method of Inoculation.  554 
As homogenous plating is essential for reliable results, a sterile inoculating loop was used to streak the agar 555 
with the corresponding bacterium (Hendrikson, 2002). The surface of the agar was streaked from the top to the 556 
centre, turned 90˚ and repeated until the plate had been turned a full 360˚ (Cappuccino and Sherman, 2008). 557 
Fig. 2: Mean zones of inhibition for each dilution of antimicrobial for each bacterium  558 
The diameters of the zones of inhibition (ZOI) for each dilution of the three antimicrobials: chlorohexidone (CHG), 559 
povodiine-iodine (PI) and green tea (GT) were measured and a mean overall ZOI calculated for each dilution rate 560 
to enable comparison of their efficacy across all bacterial species evaluated:  Staphylococcus aureus,  561 
Staphylococcus intermedius, Streptococcus uberis and Streptococcus pyogenes; ‘>’ indicates increased efficacy 562 
i.e. reduced diameters for zones of inhibition.   563 
  564 
Fig. 3: Mean diameter of zones of inhibition for natural and synthetic antimicrobials  565 
The diameters of the zones of inhibition (ZOI) surrounding each impregnated filter disk were measured and an 566 
average total ZOI calculated for synthetic antimicrobials: chlorohexidine and povodine-iodine, and green tea to 567 
enable a comparison of their efficacy to be undertaken.   568 
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